Remote Patient Monitoring Market

Remote Patient Monitoring Market Overview

Remote Patient Monitoring Market Size was valued at USD 18.23 Billion in 2023. The Global Remote Patient Monitoring industry is projected to grow from USD 21.67 Billion in 2024 to USD 88.92 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 19.30% during the forecast period (2024 - 2032). 

The increasing geriatric population and growing investments in telemedicine are the key market drivers enhancing market growth.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

July 2024: Philips expanded its remote patient monitoring solutions with the new Philips Care Orchestrator, which integrates advanced analytics to enhance patient outcomes and streamline care for chronic conditions.

June 2024: Medtronic launched the Minimed 780G insulin pump system with advanced remote monitoring, offering real-time glucose data sharing with healthcare providers to improve diabetes management and reduce hospital visits.

Remote Patient Monitoring Market Trends

• Rising  Geriatric Population to Fuels Market Growth

According to the World Health Organization the worldwide population over 60 is expected to grow from 12% in 2015 to 22% in 2050, increasing the risk of developing chronic diseases and complications. An increase in chronic diseases such as osteoarthritis, chronic obstructive pulmonary disease, diabetes, depression, heart disease and dementia are prevalent in this population. Therefore, various solutions for remote monitoring patients to treat these diseases are being increasingly used, which drives the market CAGR.

Furthermore, there is a growing need for continuous monitoring of vital signs and effective treatment of disease. For instance, according to a study published in the American Medical Informatics Association (JAMIA) Journal, remote patient monitoring boosts patient engagement in managing chronic diseases.

Technological advances and the cost advantages of remote patient monitoring have driven the adoption of remote patient monitoring technology for many years. People tend to monitor their health daily with home monitors. Patients can easily assess temperature, respiratory rate, heart rate, blood pressure and more via wearable devices in point-of-care settings without disrupting their daily lives. Devices are getting cheaper and cheaper as adoption increases. Thus, driving the  Remote Patient Monitoring market revenue.

Integration of AI and machine learning algorithms into RPM systems has allowed for more advanced predictive analytics. These systems can analyze vast amounts of patient data to predict potential health issues before they become critical, enabling proactive care.

For instance, Philips and Biofourmis are leading in AI-driven platforms providing real-time insights and early warnings for conditions like heart failure and COPD.

Remote Patient Monitoring Market Segment Insights

Remote Patient Monitoring Type Insights

The market segmentation of remote patient monitoring is based on Type includes devices, and services. The services Remote Patient Monitoring segment held the majority share in 2022 with respect to the market revenue of remote patient monitoring. Rising demand for remote patient monitoring services during the COVID-19 pandemic fueled revenue growth. 

In addition, major players' technological advancements and new product launches contribute to the growth of remote patient monitoring services for, cardiac monitoring, vital signs and blood glucose monitoring in the  market.

Remote Patient Monitoring Application Insights

Applications have bifurcated the  Remote Patient Monitoring market data into Cancer, Cardiovascular Diseases, and Diabetes. The Cardiovascular Diseases segment dominated the market in 2022, and the Diabetes segment is anticipated to be the fastest-growing segment during the period, 2024-2032. The increasing occurrence of chronic diseases and rising patient visits are the major reason for the growth of this segment in the market.

Remote Patient Monitoring End-User Insights

The market Components of Remote Patient Monitoring, based on End-User, include Hospitals, Clinics, and Others. The hospitals segment led the market in 2022 and is anticipated to be the fastest-developing segment during the period, 2024-2032, due to the growing number of prehospital patient visits. In addition, the pandemic has further improved the adoption rate due to the social-distancing norms enforced by countries.

The patient segment is anticipated to experience fastest progress during the forecast period owing to the increasing awareness among the patient population regarding the need for real-time monitoring of health parameters. The implementation of affordable health plans by payers will help patients adopt devices that embrace digital transformation. 

Thus, supporting patients in implementing affordable devices is projected to leverage the growth of the patient segment. Hence, rising End-User options for Remote Patient Monitoring positively impact the market growth

Figure 2  Remote Patient Monitoring Market Share By End-User 2024-2032 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Remote Patient Monitoring Regional Insights

By region, the study offers market insights into Asia-Pacific, Europe, North America,  and Rest of the World. The North America remote patient monitoring market accounted for USD 1.00 billion in 2022 and is projected to display a significant CAGR growth during the study period attributed to the greater adoption of monitoring devices by patients and hospital settings. Moreover, Increasing investment in the introduction of sophisticated devices for enhanced quality care of the patient pool is accountable for the region dominant market share in 2022. 

North American market players constantly focus on product development and partnership strategies to expand their business offerings in North America. Further, the United States market of remote patient monitoring held the largest market share, and the Canada market of remote patient monitoring was the fastest-growing market in the North American region.

Further, the key countries studied in the market report are The U.S, Canada, UK, Italy, Spain, Germany, France, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3  REMOTE PATIENT MONITORING MARKET SHARE BY REGION 2022 (%)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's remote patient monitoring market accounts for the second-largest market share due to the rapid adoption of the devices, favorable regulatory scenario, and availability of adequate healthcare infrastructure. In addition, strategic partnerships among the companies to offer whole remote patient monitoring to patients are contributing to the introduction of these monitoring devices in the region leading to higher adoption. 

Moreover, the UK market of remote patient monitoring held the largest market sharenwhereas Germany market of remote patient monitoring is the fast growing in the region.

The Asia-Pacific Remote Patient Monitoring Market is anticipated to grow at the fastest CAGR from 2024-2032. Rising patient responsiveness regarding blood glucose monitoring devices coupled with cardiac monitors leads to higher adoption of these devices in the region. 

In addition, the penetration of companies in rural areas and improving healthcare systems in countries such as India, Australia, and Southeast Asia are expected to drive the market. 

Key players are devising market entry strategies to expand their business presence in the Asia Pacific. Moreover, the China market of remote patient monitoring held the largest market sharenwhereas India market of remote patient monitoring is the fast growing in the Asia-Pacific region.

Remote Patient Monitoring Key Market Players & Competitive Insights

Key market players are spending a huge amount of money on research & development to increase their product lines, which will aid the market growth of remote patient monitoring. Market players are also taking numerous strategies to grow their  footprint, with vital market developments such as increased investments, contractual agreements, mergers, new product launches, and acquisitions, and collaboration with other organizations. Competitors in the remote patient monitoring industry must expand their business footprint to stay alive in an progressively competitive and mounting market atmosphere.

One of the major business strategies industries adopt in the  remote patient monitoring manufacturing to help clients and increase the market sector by increasing investment in R&D to improve solutions and services. In recent years, the remote patient monitoring industry has provided reduced disruptions and transparency in the supply chain. 

The remote patient monitoring market key player such as Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers AG (Germany), OMRON Healthcare (Japan), Boston Scientific Corporation (US), Abbott Laboratories (US), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Philips (US) and others are working on increasing the market demand by investing in research and development activities.

Philips is an American-based company that helps people to prevent disease and live healthily. Giving clinicians tools need to make a precision diagnosis and bring personalized treatment. For instance, In November 2019, Philips announced the launch of EarlyVue VS30, vital signs monitor in the U.S. The monitor aims to collect critical vital signs data and allow clinicians to appropriately identify the patient's health.

Medtronic plc is an American medical device company. It primarily operates in the United States, operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. For instance, in July 2020, Medtronic announced the clearance of Linq II insertable cardiac monitor (ICM) by the European CE mark and U.S. food and drug administration. The monitor is equipped with remote programming that allows clinicians to monitor patients and change device settings without the physical need of patients in hospitals and clinics.

Key Companies in the Remote Patient Monitoring market include

• Koninklijke Philips N.V. (Netherlands)
• Medtronic plc (Ireland)
• GE Healthcare (US)
• Cerner Corporation (US)
• Siemens Healthineers AG (Germany)
• OMRON Healthcare (Japan)
• Boston Scientific Corporation (US)
• Abbott Laboratories (US)
• Nihon Kohden Corporation (Japan)
• OSI Systems, Inc. (US)
• Philips

Remote Patient Monitoring Industry Developments

Inspire Medical Systems: First Quarter 2025 Financial Results and Inspire V System Launch: Inspire Medical Systems reported strong Q1 2025 financial results, with a 23% revenue increase. A key highlight is the milestone of over 100,000 patients receiving Inspire therapy. They also announced the full U.S. launch of the Inspire V system in May 2025, which is their newest generation of hypoglossal nerve stimulation (HNS) therapy for OSA, offering a mask-free alternative. Their investor relations page also shows upcoming presentations at MedTech conferences in June 2025.

HealthSnap: RPM Impact Hypertension Study Insights HealthSnap's newsroom highlights insights from their hypertension study, showcasing the impact of RPM. They also mention their commitment to security and privacy, having earned HITRUST Certification for the 4th consecutive year (though the news release for the certification itself is from Feb 2025). Their website also mentions recent discussions on "The Promise of Remote Patient Monitoring to Uncover and Advance Novel Risk Factors.

OMRON Healthcare: OMRON Healthcare Donates 4000 BP Monitors & Advances AFib Screening OMRON Healthcare announced its continued sponsorship of May Measurement Month (MMM), donating approximately 4,000 blood pressure monitors. This year, the donated devices include monitors that detect possible atrial fibrillation (AFib) using new AI-based Intellisense AFib technology, as well as integrated ECG technology, highlighting their focus on advanced remote blood pressure monitoring for heart health.

June 2024: Philips has upgraded its remote patient monitoring platform with AI-powered predictive analytics, enabling early intervention in chronic conditions patients.

April 2024: Medtronic has introduced an AI-driven insulin monitoring solution for diabetes management, offering real-time glucose monitoring and predictive insights. The system automatically adjusts insulin delivery based on continuous glucose monitor readings, promoting a more personalized approach to diabetes care and improving glycemic control.

March 2024: Abbott Laboratories has introduced next-generation wearable biosensors, which monitor multiple biomarkers simultaneously, providing real-time data for remote monitoring by healthcare providers, especially for patients with chronic conditions, using a cloud-based platform.

Remote Patient Monitoring Market Segmentation

Remote Patient Monitoring Type Outlook

• Devices
• Services

Remote Patient Monitoring Application Outlook

• Cancer
• Cardiovascular Diseases
• Diabetes

Remote Patient Monitoring End-User Outlook

• Payers
• Providers
• Patients

Remote Patient Monitoring Regional Outlook

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Rest of the World
  • Middle East
  • Africa
  • Latin America

Remote Patient Monitoring Market

Remote Patient Monitoring Type Outlook (USD Billion, 2024-2032)

• Devices

• Services

Remote Patient Monitoring Application Outlook (USD Billion, 2024-2032)

• Cancer

• Cardiovascular Diseases

• Diabetes

Remote Patient Monitoring End User Outlook (USD Billion, 2024-2032)

• Payers

• Providers

• Patients

Remote Patient Monitoring Regional Outlook (USD Billion, 2024-2032)

• North America Outlook (USD Billion, 2024-2032)

  • North America Remote Patient Monitoring by Type

    • Devices

    • Services

  • North America Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • North America Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • US Outlook (USD Billion, 2024-2032)

  • US Remote Patient Monitoring by Type

    • Devices

    • Services

  • US Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • US Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • CANADA Outlook (USD Billion, 2024-2032)

  • Canada Remote Patient Monitoring by Type

    • Devices

    • Services

  • Canada Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Canada Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

• Europe Outlook (USD Billion, 2024-2032)

  • Europe Remote Patient Monitoring by Type

    • Devices

    • Services

  • Europe Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Europe Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • Germany Outlook (USD Billion, 2024-2032)

  • Germany Remote Patient Monitoring by Type

    • Devices

    • Services

  • Germany Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Germany Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • France Outlook (USD Billion, 2024-2032)

  • France Remote Patient Monitoring by Type

    • Devices

    • Services

  • France Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • France Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • UK Outlook (USD Billion, 2024-2032)

  • UK Remote Patient Monitoring by Type

    • Devices

    • Services

  • UK Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • UK Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • ITALY Outlook (USD Billion, 2024-2032)

  • Italy Remote Patient Monitoring by Type

    • Devices

    • Services

  • Italy Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Italy Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • SPAIN Outlook (USD Billion, 2024-2032)

  • Spain Remote Patient Monitoring by Type

    • Devices

    • Services

  • Spain Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Spain Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • Rest Of Europe Outlook (USD Billion, 2024-2032)

  • Rest of Europe Remote Patient Monitoring by Type

    • Devices

    • Services

  • Rest of Europe Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Rest of Europe Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

• Asia-Pacific Outlook (USD Billion, 2024-2032)

  • Asia-Pacific Remote Patient Monitoring by Type

    • Devices

    • Services

  • Asia-Pacific Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Asia-Pacific Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • China Outlook (USD Billion, 2024-2032)

  • China Remote Patient Monitoring by Type

    • Devices

    • Services

  • China Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • China Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • Japan Outlook (USD Billion, 2024-2032)

  • Japan Remote Patient Monitoring by Type

    • Devices

    • Services

  • Japan Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Japan Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • India Outlook (USD Billion, 2024-2032)

  • India Remote Patient Monitoring by Type

    • Devices

    • Services

  • India Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • India Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • Australia Outlook (USD Billion, 2024-2032)

  • Australia Remote Patient Monitoring by Type

    • Devices

    • Services

  • Australia Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Australia Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • Rest of Asia-Pacific Outlook (USD Billion, 2024-2032)

  • Rest of Asia-Pacific Remote Patient Monitoring by Type

    • Devices

    • Services

  • Rest of Asia-Pacific Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Rest of Asia-Pacific Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

• Rest of the World Outlook (USD Billion, 2024-2032)

  • Rest of the World Remote Patient Monitoring by Type

    • Devices

    • Services

  • Rest of the World Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Rest of the World Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • Middle East Outlook (USD Billion, 2024-2032)

  • Middle East Remote Patient Monitoring by Type

    • Devices

    • Services

  • Middle East Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Middle East Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • Africa Outlook (USD Billion, 2024-2032)

  • Africa Remote Patient Monitoring by Type

    • Devices

    • Services

  • Africa Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Africa Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients

  • Latin America Outlook (USD Billion, 2024-2032)

  • Latin America Remote Patient Monitoring by Type

    • Devices

    • Services

  • Latin America Remote Patient Monitoring by Application

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

  • Latin America Remote Patient Monitoring by End User

    • Payers

    • Providers

    • Patients